News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • NAND-driven gains highlight rising AI storage demand, benefiting storage suppliers.
  • Western Digital shows strong free cash flow and shrinking net debt while gaining cloud and AI customer revenue.
  • Trade idea: go long WDC to capture pricing leverage, using a tight stop for valuation risk.
  • Wolfspeed offers asymmetric upside from silicon carbide adoption across EVs, fast charging, and data centers.
  • Recommended Wolfspeed trade: disciplined long with a defined entry, protective stop, and a $40 target.
  • Semiconductor materials and AI storage themes could prompt near-term rotation into tech hardware stocks.

Latest Articles

Exyn Defense Expands into Multi-Billion-Dollar Defense Sustainment Market, Bringing Field-Proven AI Autonomy to U.S. Air Force Aircraft Readiness

Exyn Defense Expands into Multi-Billion-Dollar Defense Sustainment Market, Bringing Field-Proven AI Autonomy to U.S. Air Force Aircraft Readiness

Exyn Defense, a subsidiary of Exyn Technologies, is broadening its autonomous AI capabilities from battlefield robotics to defense sustainment and readiness, starting with an aircraft inspection deployment at the U.S. Air Force Warner Robins Air Logistics Complex. This marks entry into a multi-billion-dollar market focused on maintaining and modern…

Amwell® to report second quarter 2026 operating results

Amwell® to report second quarter 2026 operating results

Amwell, a leading SaaS-based healthcare technology platform provider, will release its second quarter 2026 operating results on August 4, 2026, after market close. The management team will present an earnings call and webcast to discuss performance and business updates. Amwell offers integrated technology-enabled care solutions serving large health…

Teamshares to Release Second Quarter 2026 Earnings on August 14, 2026

Teamshares to Release Second Quarter 2026 Earnings on August 14, 2026

Teamshares Inc. (NASDAQ: TMS), a tech-enabled acquiror of small and medium-sized enterprises (SMEs), will release its second quarter 2026 financial results before the market opens on August 14, 2026. The company will also host a conference call to discuss these results. Teamshares focuses on acquiring companies from retiring owners and integrating …

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

NewAmsterdam Pharma and Menarini Group received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the EMA recommending marketing authorization for Ubeslo® (obicetrapib monotherapy) and Evlarco® (obicetrapib plus ezetimibe fixed-dose combination) for patients with primary hypercholesterolemia in Europe. This recomm…

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Immutep Limited announced that an abstract detailing health-related quality of life data from its investigator-initiated Phase II EFTISARC-NEO trial has been accepted for presentation at the ESMO Congress 2026. The trial evaluates eftilagimod alfa, a first-in-class MHC Class II agonist, combined with pembrolizumab and radiotherapy for soft tissue s…

Gentex Reports Second Quarter 2026 Financial Results

Gentex Reports Second Quarter 2026 Financial Results

Gentex Corporation announced its second quarter 2026 financial results, posting a slight sales decrease but significant profit and margin improvements driven by strong North American automotive performance, growth in premium audio, and other non-automotive segments. The company also boosted earnings per share by 26% year-over-year and increased gro…

Liberty Global Reports Q2 2026 Results

Liberty Global Reports Q2 2026 Results

Liberty Global Ltd. announced its Q2 2026 results highlighting continued strategic execution including key steps towards the planned spin-off of Ziggo Group by mid-2027. The company's telecom operations saw positive broadband net adds across its subsidiaries, including VodafoneZiggo (Benelux), Telenet (Belgium), Virgin Media O2 (UK), and Virgin Med…

Bank Rate to Stay at 3.75% as Inflation Risks from Middle East Persist

Bank Rate to Stay at 3.75% as Inflation Risks from Middle East Persist

A July 21-24 poll of 70 economists finds unanimous expectation that the Bank of England will keep its policy rate at 3.75% on Thursday and likely maintain it through much of 2026 as inflation remains above target. A temporary dip in June inflation to 2.6% followed a brief easing of conflict in the Gulf and lower fuel prices, but renewed hostilities…

Chris Brown Enters Guilty Plea for Affray in London Nightclub Incident

Chris Brown Enters Guilty Plea for Affray in London Nightclub Incident

U.S. singer Chris Brown and co-defendant Omololu Akinlolu pleaded guilty to affray over a February 2023 incident at Tape nightclub in London. Prosecutors said they will not pursue separate charges alleging attempted grievous bodily harm or assault causing actual bodily harm. Sentencing is set for October 26 at Southwark Crown Court.

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Mir A. Imran, a director and significant shareholder in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), recently executed a purchase of 36,000 shares of the company's Class A Common Stock. This transaction, valued at $24,839, occurred against a backdrop of recent corporate developments, including the announcement of positive initial data from a Pha…

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Inc., through its subsidiary Zorronet Ltd., has entered into two strategic collaborations with Samura s.r.o. to deploy AI-powered monitoring solutions in Central and Eastern Europe. These collaborations target smart pest management in agriculture and the protection of critical transportation infrastructure, leveraging AI to improve efficiency…

Buy the Pullback in AppLovin - Growth Intact, Market Flinching

Buy the Pullback in AppLovin - Growth Intact, Market Flinching

AppLovin (APP) pulled back on sentiment and headline risk, but fundamentals remain strong: Q1 2026 revenue near $1.8B (roughly 59% YoY), EPS near $11.80, and management is repurchasing stock. Valuation is rich but supported by high returns and fast top-line growth. This trade idea is a disciplined long with clear entry, stop and target, sized to a …

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics Inc. (NASDAQ: CYTK) Executive Vice President of Research & Development Fady Malik executed a series of transactions on July 21, 2026, selling 3,500 shares of common stock while simultaneously exercising non-qualified stock options to acquire an equal number of shares. The sale was reported at $80.59 per share, totaling $282,065, while …